DE69614419D1 - Transdermale Formulierung eines Mittels muscarinischer Wirkung - Google Patents

Transdermale Formulierung eines Mittels muscarinischer Wirkung

Info

Publication number
DE69614419D1
DE69614419D1 DE69614419T DE69614419T DE69614419D1 DE 69614419 D1 DE69614419 D1 DE 69614419D1 DE 69614419 T DE69614419 T DE 69614419T DE 69614419 T DE69614419 T DE 69614419T DE 69614419 D1 DE69614419 D1 DE 69614419D1
Authority
DE
Germany
Prior art keywords
transdermal formulation
muscarinic agent
muscarinic
agent
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69614419T
Other languages
English (en)
Other versions
DE69614419T2 (de
Inventor
Franklin P Bymaster
Harlan E Shannon
Lisa A Shipley
Kirti H Valia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69614419D1 publication Critical patent/DE69614419D1/de
Application granted granted Critical
Publication of DE69614419T2 publication Critical patent/DE69614419T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69614419T 1995-02-17 1996-02-01 Transdermale Formulierung eines Mittels muscarinischer Wirkung Expired - Fee Related DE69614419T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39044595A 1995-02-17 1995-02-17
US48101695A 1995-06-07 1995-06-07

Publications (2)

Publication Number Publication Date
DE69614419D1 true DE69614419D1 (de) 2001-09-20
DE69614419T2 DE69614419T2 (de) 2002-05-23

Family

ID=27013141

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69614419T Expired - Fee Related DE69614419T2 (de) 1995-02-17 1996-02-01 Transdermale Formulierung eines Mittels muscarinischer Wirkung

Country Status (22)

Country Link
US (1) US5858393A (de)
EP (1) EP0727208B1 (de)
JP (1) JPH11505513A (de)
KR (1) KR19980702239A (de)
CN (1) CN1181007A (de)
AR (1) AR002027A1 (de)
AU (1) AU700023B2 (de)
BR (1) BR9607722A (de)
CA (1) CA2212874A1 (de)
CO (1) CO4700408A1 (de)
CZ (1) CZ255097A3 (de)
DE (1) DE69614419T2 (de)
ES (1) ES2159683T3 (de)
FI (1) FI973362A (de)
HU (1) HUP9802070A3 (de)
IL (1) IL116997A0 (de)
NO (1) NO973715L (de)
NZ (1) NZ302147A (de)
PE (1) PE17897A1 (de)
TR (1) TR199700799T1 (de)
WO (1) WO1996025154A1 (de)
YU (1) YU6196A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US6417227B1 (en) 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
WO2001030316A2 (en) * 1999-10-28 2001-05-03 3M Innovative Properties Company Transdermal drug delivery devices comprising (r)-(z)-1-azabicyclo(2.2.1)heptan-3-one, 0-(3(3-methoxyphenyl)-2-propynyl)oxime
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
US20070264130A1 (en) * 2006-01-27 2007-11-15 Phluid, Inc. Infusion Pumps and Methods for Use
US8986253B2 (en) * 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
WO2009143188A2 (en) * 2008-05-19 2009-11-26 Diperna Paul M Disposable pump reservoir and related methods
US7943187B2 (en) * 2008-05-23 2011-05-17 Bakr Rabie Paeoniflorin preparations and uses thereof for fat reduction
EP2363116A1 (de) 2008-06-25 2011-09-07 US Worldmeds LLC Lofexidin enthaltende Formulierungen mit verzögerter Freisetzung zur oralen Verabreichung
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
WO2010033878A2 (en) * 2008-09-19 2010-03-25 David Brown Solute concentration measurement device and related methods
EP3284494A1 (de) 2009-07-30 2018-02-21 Tandem Diabetes Care, Inc. Tragbares infusionspumpensystem
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
IT1233860B (it) * 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5238933A (en) * 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions
PT714394E (pt) * 1993-08-19 2001-12-28 Novo Nordisk As Metodo antipsicotico com derivados de tiadiazol e oxadiazol

Also Published As

Publication number Publication date
CZ255097A3 (en) 1997-12-17
HUP9802070A2 (hu) 1999-02-01
AR002027A1 (es) 1998-01-07
PE17897A1 (es) 1997-06-12
ES2159683T3 (es) 2001-10-16
AU700023B2 (en) 1998-12-17
YU6196A (sh) 1998-09-18
CA2212874A1 (en) 1996-08-22
AU4774296A (en) 1996-09-04
WO1996025154A1 (en) 1996-08-22
CN1181007A (zh) 1998-05-06
EP0727208B1 (de) 2001-08-16
KR19980702239A (ko) 1998-07-15
CO4700408A1 (es) 1998-12-29
FI973362A0 (fi) 1997-08-15
TR199700799T1 (xx) 1998-02-21
US5858393A (en) 1999-01-12
HUP9802070A3 (en) 2000-09-28
JPH11505513A (ja) 1999-05-21
DE69614419T2 (de) 2002-05-23
MX9706143A (es) 1997-11-29
IL116997A0 (en) 1996-06-18
NZ302147A (en) 1998-10-28
NO973715D0 (no) 1997-08-12
BR9607722A (pt) 1998-07-14
NO973715L (no) 1997-08-12
FI973362A (fi) 1997-08-15
EP0727208A1 (de) 1996-08-21

Similar Documents

Publication Publication Date Title
DE69614419T2 (de) Transdermale Formulierung eines Mittels muscarinischer Wirkung
DE69510448D1 (de) Vorrichtung eines zweikammerherzschrittmachers
BR9505408A (pt) Composição terapêutica de aplicacão tópica e utilização de um antagonista de substância P
DE69316993D1 (de) Untersuchung eines körpers
BR9506388A (pt) Processo para preparação de um composto à base de silício ou silila biogicamente ativo aplicação da silila composição terapêutica e composição cosmética contendo silila
DE69830418D1 (de) Messen der wirksamkeit eines sterilisationsverfahren
DE69423289D1 (de) Oberflächenmodifikation mittels eines gleitfähigen Silikons
DE69514298T2 (de) Navigationsvorrichtung eines sich bewegenden Objektes
DE69218932T2 (de) Transdermale therapeutische Formulierung
DE59711477D1 (de) Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
DE69515845D1 (de) Untersuchung eines diamanten
DE69326636D1 (de) Äusserliche Anwendung eines Kiefernextrakt enthaltenden, haarregenerierenden Mittels
ATE160934T1 (de) Verwendung eines antagonisten der substanz p in einer topischen zusammensetzung als antitranspirationsmittel
BR9600688A (pt) Compostos heterocíclicos aromáticos composição farmacêutica uso de um composto e composição cosmética
BR9600216A (pt) Formulação de emplastro de xanomelina transdérmica
DE69405684T2 (de) Effektivitätsfeststellung eines Katalysators
DE69606665D1 (de) N-Acyl-2-arylcyclopropylmethylamin-Derivate als melatonergisches Mittel
DE69705931T2 (de) Positionsbestimmung eines endgerätes mittels mehrerer strahlungskeulen
BR9606596A (pt) Composto processo para preparar um composto composição cosmética ou farmacéutica e uso de um composto
BR9606638A (pt) Composto processo de preparação de um composto composição farmacêutica e uso de um composto
FI973230A0 (fi) Uusi farmaseuttinen formulaatio
DE9320586U1 (de) Topische Formulierung eines solubilisierten Ginkgo-biloba-Extraktes
DE69610917T2 (de) Abstützeinrichtung eines fahrzeugs
DE69608430D1 (de) Konfiguration eines telekommunikationsschalters
DE69617931T2 (de) Konfiguration eines telekommunikationsschalters

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee